Article
BRCA mutations in the management of breast cancer: the state of the art.
Nature reviews. Clinical oncology - 1 Dec 2010
Narod Steven A
Abstract excerpt
Genetic testing for BRCA1 and BRCA2 mutations is gaining acceptance in clinical oncology worldwide and may help target unaffected high-risk women for prevention and for close surveillance. Annual screening with MRI seems to be an effective surveillance strategy, but the long term follow-up of wom...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
